• Country
    Clear
  • Type
  • Compatibility Level
  • Thematic
  • Jurisdiction
2,477 Data sources

  • NL
  • IT
  • AT

  • DANS Data Station Physical and Technical Sciences

    more_vert
  • more_vert
  • APICURON is a database to credit and acknowledge the work of biocurators, it collects and aggregates biocuration events from third party resources and generates achievements and leaderboards.

    more_vert
  • more_vert
  • more_vert
  • more_vert
  • Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported to experience a potential drug-drug interaction, with 16% experiencing a major event. Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University, Nijmegen (the Netherlands), this site was established in 2017 in response to the need for improved management of DDIs with anti-cancer agents.

    more_vert
  • more_vert
  • MultifacetedProtDB is an integrated and manually curated database providing a comprehensive collection of multifunctional UniProt/SwissProt human proteins.

    more_vert
  • more_vert
  • chevron_left
  • 3
  • 4
  • 5
  • 6
  • 7
  • chevron_right
2,477 Data sources
  • DANS Data Station Physical and Technical Sciences

    more_vert
  • more_vert
  • APICURON is a database to credit and acknowledge the work of biocurators, it collects and aggregates biocuration events from third party resources and generates achievements and leaderboards.

    more_vert
  • more_vert
  • more_vert
  • more_vert
  • Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported to experience a potential drug-drug interaction, with 16% experiencing a major event. Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University, Nijmegen (the Netherlands), this site was established in 2017 in response to the need for improved management of DDIs with anti-cancer agents.

    more_vert
  • more_vert
  • MultifacetedProtDB is an integrated and manually curated database providing a comprehensive collection of multifunctional UniProt/SwissProt human proteins.

    more_vert
  • more_vert
  • chevron_left
  • 3
  • 4
  • 5
  • 6
  • 7
  • chevron_right